{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:05:54Z","timestamp":1791353154774,"version":"4.3.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["11669"],"award-info":[{"award-number":["11669"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["8861"],"award-info":[{"award-number":["8861"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001755","name":"Mesothelioma Applied Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001755","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13045-017-0510-3","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T10:26:10Z","timestamp":1500287170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an \u201cALT-like\u201d phenotype in diffuse malignant peritoneal mesothelioma cells"],"prefix":"10.1186","volume":"10","author":[{"given":"Graziella","family":"Cimino-Reale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gandellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Santambrogio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Recagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Zaffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1811-4407","authenticated-orcid":false,"given":"Marco","family":"Folini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,17]]},"reference":[{"key":"510_CR1","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.2174\/1381612820666140630095918","volume":"20","author":"F Santambrogio","year":"2014","unstructured":"Santambrogio F, Gandellini P, Cimino-Reale G, Zaffaroni N, Folini M. MicroRNA-dependent regulation of telomere maintenance mechanisms: a field as much unexplored as potentially promising. Curr Pharm Des. 2014;20:6404\u201321.","journal-title":"Curr Pharm Des"},{"key":"510_CR2","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1016\/j.febslet.2010.06.009","volume":"584","author":"JD Henson","year":"2010","unstructured":"Henson JD, Reddel RR. Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers. FEBS Lett. 2010;584:3800\u201311.","journal-title":"FEBS Lett"},{"key":"510_CR3","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/1078-0432.CCR-16-1113","volume":"23","author":"AD Singhi","year":"2017","unstructured":"Singhi AD, Liu TC, Roncaioli JL, Cao D, Zeh HJ, Zureikat AH, et al. Alternative lengthening of telomeres and loss of DAXX\/ATRX expression predicts metastatic disease and poor survival in patients with pancreatic neuroendocrine tumours. Clin Cancer Res. 2017;23:600\u20139.","journal-title":"Clin Cancer Res"},{"key":"510_CR4","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/modpathol.2015.114","volume":"28","author":"JY Liau","year":"2015","unstructured":"Liau JY, Lee JC, Tsai JH, Yang CY, Liu TL, Ke ZL, et al. Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas. Mod Pathol. 2015;28:1545\u201354.","journal-title":"Mod Pathol"},{"key":"510_CR5","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1158\/1078-0432.CCR-08-0099","volume":"14","author":"R Villa","year":"2008","unstructured":"Villa R, Daidone MG, Motta R, Venturini L, De Marco C, Vannelli A, et al. Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. Clin Cancer Res. 2008;14:4134\u201340.","journal-title":"Clin Cancer Res"},{"key":"510_CR6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/neuonc\/nos083","volume":"14","author":"L Venturini","year":"2012","unstructured":"Venturini L, Daidone MG, Motta R, Cimino-Reale G, Hoare SF, Gronchi A, et al. Telomere maintenance mechanisms in malignant peripheral nerve sheath tumours: expression and prognostic relevance. Neuro Oncol. 2012;14:736\u201344.","journal-title":"Neuro Oncol"},{"key":"510_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13073-016-0324-x","volume":"8","author":"MA Jafri","year":"2016","unstructured":"Jafri MA, Ansari SA, Alqahtani MH, Shay JW. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med. 2016;8:69.","journal-title":"Genome Med"},{"key":"510_CR8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrc3166","volume":"11","author":"AL Kasinski","year":"2011","unstructured":"Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011;11:849\u201364.","journal-title":"Nat Rev Cancer"},{"key":"510_CR9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/emmm.201100209","volume":"4","author":"MV Iorio","year":"2012","unstructured":"Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4:143\u201359.","journal-title":"EMBO Mol Med"},{"key":"510_CR10","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1021\/acs.jmedchem.6b00777","volume":"59","author":"V Span\u00f2","year":"2016","unstructured":"Span\u00f2 V, Pennati M, Parrino B, Carbone A, Montalbano A, Cilibrasi V, et al. Preclinical activity of new [1,2]oxazolo[5,4-e]isoindole derivatives in diffuse malignant peritoneal mesothelioma. J Med Chem. 2016;59:7223\u201338.","journal-title":"J Med Chem"},{"key":"510_CR11","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/nprot.2010.124","volume":"5","author":"M Kimura","year":"2010","unstructured":"Kimura M, Stone RC, Hunt SC, Skurnick J, Lu X, Cao X, et al. Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths. Nat Protoc. 2010;5:1596\u2013607.","journal-title":"Nat Protoc"},{"key":"510_CR12","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nbt.1587","volume":"27","author":"JD Henson","year":"2009","unstructured":"Henson JD, Cao Y, Huschtscha LI, Chang AC, Au AY, Pickett HA, et al. DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Nat Biotechnol. 2009;27:1181\u20135.","journal-title":"Nat Biotechnol"},{"key":"510_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13045-016-0387-6","volume":"10","author":"R Bezawy El","year":"2017","unstructured":"El Bezawy R, De Cesare M, Pennati M, Deraco M, Gandellini P, Zuco V, et al. Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism. J Hematol Oncol. 2017;10:19.","journal-title":"J Hematol Oncol"},{"key":"510_CR14","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1038\/sj.onc.1203061","volume":"18","author":"H Li","year":"1999","unstructured":"Li H, Cao Y, Berndt MC, Funder JW, Liu JP. Molecular interactions between telomerase and the tumour suppressor protein p53 in vitro. Oncogene. 1999;18:6785\u201394.","journal-title":"Oncogene"},{"key":"510_CR15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jbi.2011.05.002","volume":"44","author":"H Dweep","year":"2011","unstructured":"Dweep H, Sticht C, Pandey P, Gretz N. miRWalk\u2014database: prediction of possible miRNA binding sites by \u201cwalking\u201d the genes of three genomes. J Biomed Inform. 2011;44:839\u201347.","journal-title":"J Biomed Inform"},{"key":"510_CR16","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cell.2006.07.031","volume":"126","author":"KC Miranda","year":"2006","unstructured":"Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006;126:1203\u201317.","journal-title":"Cell"},{"key":"510_CR17","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s00018-013-1551-6","volume":"71","author":"A Stroynowska-Czerwinska","year":"2014","unstructured":"Stroynowska-Czerwinska A, Fiszer A, Krzyzosiak WJ. The panorama of miRNA-mediated mechanisms in mammalian cells. Cell Mol Life Sci. 2014;71:2253\u201370. heteroduplexes.","journal-title":"Cell Mol Life Sci"},{"key":"510_CR18","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/nm.2227","volume":"16","author":"A Swarbrick","year":"2010","unstructured":"Swarbrick A, Woods SL, Shaw A, Balakrishnan A, Phua Y, Nguyen A, et al. miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. Nat Med. 2010;16:1134\u201340.","journal-title":"Nat Med"},{"key":"510_CR19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ncb2142","volume":"13","author":"MT Epping","year":"2011","unstructured":"Epping MT, Meijer LA, Krijgsman O, Bos JL, Pandolfi PP, Bernards R. TSPYL5 suppresses p53 levels and function by physical interaction with USP7. Nat Cell Biol. 2011;13:102\u20138.","journal-title":"Nat Cell Biol"},{"key":"510_CR20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrg3162","volume":"13","author":"AE Pasquinelli","year":"2012","unstructured":"Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012;13:271\u201382.","journal-title":"Nat Rev Genet"},{"key":"510_CR21","doi-asserted-by":"crossref","first-page":"50976","DOI":"10.1074\/jbc.M402502200","volume":"279","author":"I Shats","year":"2004","unstructured":"Shats I, Milyavsky M, Tang X, Stambolsky P, Erez N, Brosh R, et al. p53-dependent down-regulation of telomerase is mediated by p21waf1. J Biol Chem. 2004;279:50976\u201385.","journal-title":"J Biol Chem"},{"key":"510_CR22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ccell.2015.08.003","volume":"28","author":"M Ramamoorthy","year":"2015","unstructured":"Ramamoorthy M, Smith S. Loss of ATRX suppresses resolution of telomere cohesion to control recombination in ALT cancer cells. Cancer Cell. 2015;28:357\u201369.","journal-title":"Cancer Cell"},{"key":"510_CR23","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1093\/nar\/gkr492","volume":"39","author":"AR Yoon","year":"2011","unstructured":"Yoon AR, Gao R, Kaul Z, Choi IK, Ryu J, Noble JR, et al. MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3\u2032 untranslated region. Nucleic Acids Res. 2011;39:8078\u201391.","journal-title":"Nucleic Acids Res"},{"key":"510_CR24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1476-4598-13-80","volume":"13","author":"HM Jung","year":"2014","unstructured":"Jung HM, Phillips BL, Chan EK. miR-375 activates p21 and suppresses telomerase activity by coordinately regulating HPV E6\/E7, E6AP, CIP2A, and 14-3-3\u03b6. Mol Cancer. 2014;13:80.","journal-title":"Mol Cancer"},{"key":"510_CR25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bbrc.2010.01.045","volume":"392","author":"EJ Kim","year":"2010","unstructured":"Kim EJ, Lee SY, Kim TR, Choi SI, Cho EW, Kim KC, Kim IG. TSPYL5 is involved in cell growth and the resistance to radiation in A549 cells via the regulation of p21(WAF1\/Cip1) and PTEN\/AKT pathway. Biochem Biophys Res Commun. 2010;392:448\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"510_CR26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/13543776.2016.1181172","volume":"26","author":"RJ Man","year":"2016","unstructured":"Man RJ, Chen LW, Zhu HL. Telomerase inhibitors: a patent review (2010-2015). Expert Opin Ther Pat. 2016;26:679\u201388.","journal-title":"Expert Opin Ther Pat"},{"key":"510_CR27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nsmb.3106","volume":"22","author":"HA Pickett","year":"2015","unstructured":"Pickett HA, Reddel RR. Molecular mechanisms of activity and derepression of alternative lengthening of telomeres. Nat Struct Mol Biol. 2015;22:875\u201380.","journal-title":"Nat Struct Mol Biol"},{"key":"510_CR28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2011.12.028","volume":"148","author":"J Hu","year":"2012","unstructured":"Hu J, Hwang SS, Liesa M, Gan B, Sahin E, Jaskelioff M, et al. Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell. 2012;148:651\u201363.","journal-title":"Cell"},{"key":"510_CR29","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1349-7006.2010.01611.x","volume":"101","author":"W Chen","year":"2010","unstructured":"Chen W, Xiao BK, Liu JP, Chen SM, Tao ZZ. Alternative lengthening of telomeres in hTERT-inhibited laryngeal cancer cells. Cancer Sci. 2010;101:1769\u201376.","journal-title":"Cancer Sci"},{"key":"510_CR30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nsmb.2754","volume":"21","author":"RJ O'Sullivan","year":"2014","unstructured":"O'Sullivan RJ, Arnoult N, Lackner DH, Oganesian L, Haggblom C, Corpet A, et al. Rapid induction of alternative lengthening of telomeres by depletion of the histone chaperone ASF1. Nat Struct Mol Biol. 2014;21:167\u201374.","journal-title":"Nat Struct Mol Biol"},{"key":"510_CR31","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","volume":"49","author":"D Baratti","year":"2013","unstructured":"Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer. 2013;49:3140\u20138.","journal-title":"Eur J Cancer"},{"key":"510_CR32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4251\/wjgo.v2.i2.76","volume":"2","author":"M Deraco","year":"2010","unstructured":"Deraco M, Baratti D, Cabras AD, Zaffaroni N, Perrone F, Villa R, et al. Experience with peritoneal mesothelioma at the Milan National Cancer Institute. World J Gastrointest Oncol. 2010;2:76\u201384.","journal-title":"World J Gastrointest Oncol"},{"key":"510_CR33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2015.01.044","volume":"360","author":"D Zhang","year":"2015","unstructured":"Zhang D, Xiao YF, Zhang JW, Xie R, Hu CJ, Tang B, et al. miR-1182 attenuates gastric cancer proliferation and metastasis by targeting the open reading frame of hTERT. Cancer Lett. 2015;360:151\u20139.","journal-title":"Cancer Lett"},{"key":"510_CR34","doi-asserted-by":"crossref","unstructured":"Song G, Wang R, Guo J, Liu X, Wang F, Qi Y, et al miR-346 and miR-138 competitively regulate hTERT in GRSF1- and AGO2-dependent manners, respectively. Sci Rep. 2015;5:15793","DOI":"10.1038\/srep15793"},{"key":"510_CR35","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1038\/srep08201","volume":"5","author":"T Ohira","year":"2015","unstructured":"Ohira T, Naohiro S, Nakayama Y, Osaki M, Okada F, Oshimura M, et al. miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells. Sci Rep. 2015;5:8201.","journal-title":"Sci Rep"},{"key":"510_CR36","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/leu.2011.81","volume":"25","author":"A Watanabe","year":"2011","unstructured":"Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, Iwamoto K, et al. The role of microRNA-150 as a tumour suppressor in malignant lymphoma. Leukemia. 2011;25:1324\u201334.","journal-title":"Leukemia"},{"key":"510_CR37","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1126\/science.1222394","volume":"336","author":"JW Shay","year":"2012","unstructured":"Shay JW, Reddel RR, Wright WE. Cancer. Cancer and telomeres\u2014an ALTernative to telomerase. Science. 2012;336:1388\u201390.","journal-title":"Science"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-017-0510-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T11:23:40Z","timestamp":1569842620000},"score":1,"resource":{"primary":{"URL":"http:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-017-0510-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,17]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["510"],"URL":"https:\/\/doi.org\/10.1186\/s13045-017-0510-3","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,17]]},"article-number":"140"}}